Record Monthly Enrollment Achieved in SeaStar Medicals Pivotal Adult AKI Trial
| ICU Stock | USD 1.84 0.02 1.08% |
Slightly above 61% of LMF Acquisition's investor base is looking to short. The analysis of the overall investor sentiment regarding LMF Acquisition Opportunities suggests that many traders are alarmed. LMF Acquisition's investing sentiment can be driven by a variety of factors including economic data, LMF Acquisition's earnings reports, geopolitical events, and overall market trends.
LMF |
DENVER, Nov. 01, 2024 -- SeaStar Medical Holding Corporation , a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, reports setting a new monthly enrollment record with 10 critically ill acute kidney injury patients added to the NEUTRALIZE-AKI pivotal trial during the past month, bringing total enrollment to 56. This trial is evaluating the safety and efficacy of the Company
Read at finance.yahoo.com
 |
LMF Acquisition Fundamental Analysis
We analyze LMF Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LMF Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LMF Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
LMF Acquisition is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
LMF Acquisition Oppo Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LMF Acquisition stock to make a market-neutral strategy. Peer analysis of LMF Acquisition could also be used in its relative valuation, which is a method of valuing LMF Acquisition by comparing valuation metrics with similar companies.
Peers
LMF Acquisition Related Equities
| QNRX | Quoin Pharmaceuticals | 6.45 | ||||
| ZVSA | ZyVersa Therapeutics | 2.52 | ||||
| PALI | Palisade Bio | 1.03 | ||||
| REVB | Revelation Biosciences | 0.45 | ||||
| BDRX | Biodexa Pharmaceticals | 0.46 | ||||
| SONN | Sonnet Biotherapeutics | 1.96 | ||||
| IMMX | Immix Biopharma | 2.59 | ||||
| UNCY | Unicycive Therapeutics | 3.23 | ||||
| VRAX | Virax Biolabs | 6.91 | ||||
| ALLR | Allarity Therapeutics | 7.00 |
Additional Tools for LMF Stock Analysis
When running LMF Acquisition's price analysis, check to measure LMF Acquisition's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LMF Acquisition is operating at the current time. Most of LMF Acquisition's value examination focuses on studying past and present price action to predict the probability of LMF Acquisition's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LMF Acquisition's price. Additionally, you may evaluate how the addition of LMF Acquisition to your portfolios can decrease your overall portfolio volatility.